Newsroom

Lupin Receives “Best New Manufacturer of the Year” Award from AmerisourceBergen

July 30, 2007

   

Lupin receives final approval for Amlodipine Tablets

July 12, 2007

   

Lupin announces Final Approval of Trandolapril Tablets

June 13, 2007

   

Lupin Receives US FDA Approval for Ziprasidone HCl Capsules

May 22, 2007

   

Lupin Announces Final FDA Approval of Cefdinir for Oral
Suspension, 250 mg/5 mL, Launches Entire Product Family.

May 8, 2007

   

Lupin Receives US FDA Approval for Novel Formulation of Suprax® Suspension

April 12, 2007

   

Lupin Receives US FDA Approval for Sertraline.

February 7, 2007

   

Lupin Announces Tentative of Trandolapril Tablets.

December 12, 2006

   

Lupin Receives Final Approval for Lisinopril-HCTZ Tablets.

September 28, 2006

   

Lupin Announces Approval of Ceftriaxone 10G vials.

September 14, 2006

   

Lupin Announces District Court Ruling on Ramipril.

July 19, 2006

   

Lupin Announces Approval of Meloxicam Tablets.

July 19, 2006

   

Lupin Receives Final Approval for Quinapril Tablets.

June 20, 2006

   

Lupin Announces Final FDA Approval of Cefdinir for Oral Suspension.

June 6, 2006

   

Lupin Announces Final FDA Approval of Cefdinir Capsules.

May 23, 2006

   

Lupin’s US Subsidiary Enters Into Collaboration to Promote Atopiclair Nonsteroidal Cream to Pediatricians in the U.S.

March 3, 2006

   

Lupin to Reorganize Sale Structure for Suprax

February 21, 2006

   

Lupin Receives US FDA Approval for Cefprozil Suspensions.

December 20, 2005

   

Lupin Receives US FDA Approval for Cefprozil Tablets.

December 9, 2005

   

Lupin Receives US FDA Approval for Cephalexin Capsules.

December 1, 2005

   

Copyright © 2006. All rights reserved.
Created and Designed by GM